Literature DB >> 18843754

What can we learn from treatment-induced changes in rheumatoid factor and anti-citrullinated Peptide antibodies?

Francesca Bobbio-Pallavicini, Roberto Caporali, Serena Bugatti, Carlomaurizio Montecucco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18843754

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  6 in total

1.  Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China.

Authors:  Chun Li; X R Wang; H J Ji; X Y Zhang; X F Li; L Z Wang; C H Wang; Y F Wang; Rong Yang; G C Wang; Xin Lu; Ping Zhu; L N Chen; H T Jin; J T Liu; X Y Liu; Lin Sun; H Y Chen; Ping Wei; J X Wang; L F Cui; Rong Shu; B L Liu; Z L Zhang; G T Li; Z B Li; Jing Yang; J F Li; Bin Jia; F X Zhang; J M Tao; S L Han; J Y Lin; M Q Wei; X M Liu; Dan Ke; S X Hu; Cong Ye; X Y Yang; Hao Li; C B Huang; Ming Gao; Bei Lai; X F Li; L J Song; Yi Wang; X Y Wang; Y D Tang; Yin Su; Rong Mu; Z G Li
Journal:  Clin Rheumatol       Date:  2017-03-24       Impact factor: 2.980

Review 2.  [Antibodies against citrullinated peptides in clinical practice and research].

Authors:  R Engelmann; B Müller-Hilke
Journal:  Z Rheumatol       Date:  2009-08       Impact factor: 1.372

Review 3.  Inflammatory lesions in the bone marrow of rheumatoid arthritis patients: a morphological perspective.

Authors:  Serena Bugatti; Antonio Manzo; Roberto Caporali; Carlomaurizio Montecucco
Journal:  Arthritis Res Ther       Date:  2012-12-27       Impact factor: 5.156

4.  Circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.

Authors:  Mahmood M T M Ally; Bridget Hodkinson; Pieter W A Meyer; Eustasius Musenge; Gregory R Tintinger; Mohammed Tikly; Ronald Anderson
Journal:  BMC Musculoskelet Disord       Date:  2015-05-29       Impact factor: 2.362

5.  In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response.

Authors:  Emma C de Moel; Veerle F A M Derksen; Leendert A Trouw; Holger Bang; Gerard Collée; Leroy R Lard; Sofia Ramiro; Tom W J Huizinga; Cornelia F Allaart; René E M Toes; Diane van der Woude
Journal:  Arthritis Res Ther       Date:  2019-01-18       Impact factor: 5.156

Review 6.  B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers.

Authors:  Serena Bugatti; Barbara Vitolo; Roberto Caporali; Carlomaurizio Montecucco; Antonio Manzo
Journal:  Biomed Res Int       Date:  2014-04-29       Impact factor: 3.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.